<?xml version="1.0" encoding="UTF-8"?>
<p>Participants were screened by rapid NP PCR approved under a US Food and Drug Administration Emergency Use Authorization (ID NOW, Abbott Laboratories, Chicago, IL). Swabs were tested immediately after sampling, without being placed in viral transport media. Individuals who tested positive by NP PCR were offered to be re‐tested if they returned in 1‐2 weeks.</p>
